Covid-19 vaccine developer AstraZeneca agrees to buy rare disease firm Alexion for $39 billion

Retrieved on: 2020-12-12 18:22:48

Tags for this article:

Click the tags to see associated articles and topics

Covid-19 vaccine developer AstraZeneca agrees to buy rare disease firm Alexion for $39 billion. View article details on hiswai:

Excerpt

New York (CNN Business) Leading <b>Covid-19</b> vaccine developer AstraZeneca agreed on Saturday to buy Boston pharmaceutical firm Alexion (ALXN) ...

Article found on: www.cnn.com